Transfection by cationic gemini lipids and surfactants.

Area of Science:

• Biotechnology
• Molecular Biology
• Nanotechnology

Background:

• Genetic diseases stem from defective genes or mutations, treatable via gene therapy.
• RNA interference (RNAi) using small interfering RNA (siRNA) can address disorders of elevated protein expression.
• Viral vectors, while effective for polynucleotide delivery, pose risks to patients.

Purpose of the Study:

• To review recent advancements in cationic lipids as non-viral transfection vectors.
• To highlight the potential of gemini surfactants in gene and RNA delivery.

Main Methods:

• Discussion of non-viral vector systems for gene and RNA delivery.
• Focus on cationic lipids, including gemini surfactants, as transfection agents.
• Review of recent scientific literature on cationic lipid-based delivery systems.

Main Results:

• Cationic lipids offer a safer alternative to viral vectors for delivering DNA and RNA into cells.
• Gemini surfactants, characterized by multiple head groups and tails, show promise as efficient transfection agents.
• Progress in cationic lipid design enhances their utility in gene therapy and RNAi applications.

Conclusions:

• Cationic lipids, especially geminis, represent a significant advancement in non-viral gene delivery.
• These vectors hold potential for treating genetic disorders and protein-related diseases.
• Further research into cationic lipids could lead to improved and safer therapeutic strategies.